These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1165 related items for PubMed ID: 22882676

  • 1. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y, Varol U, Atmaca H, Kisim A, Sezgin C, Karabulut B, Uzunoglu S, Uslu R, Karaca B.
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [Abstract] [Full Text] [Related]

  • 2. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
    Surmeli Z, Gursoy P, Erdogan AP, Bozkurt E, Atmaca H, Uzunoglu S, Sezgin C, Şanlı UA, Uslu R, Karaca B.
    Tumour Biol; 2016 Mar; 37(3):3665-73. PubMed ID: 26462835
    [Abstract] [Full Text] [Related]

  • 3. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells.
    Kar S, Palit S, Ball WB, Das PK.
    Apoptosis; 2012 Jul; 17(7):735-47. PubMed ID: 22453599
    [Abstract] [Full Text] [Related]

  • 4. The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.
    Morgan C, Lewis PD, Jones RM, Bertelli G, Thomas GA, Leonard RC.
    Acta Oncol; 2007 Jul; 46(5):669-77. PubMed ID: 17562444
    [Abstract] [Full Text] [Related]

  • 5. Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro.
    Mani J, Vallo S, Barth K, Makarević J, Juengel E, Bartsch G, Wiesner C, Haferkamp A, Blaheta RA.
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):250-5. PubMed ID: 22450844
    [Abstract] [Full Text] [Related]

  • 6. Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combination.
    Sanli UA, Gorumlu G, Erten C, Gul MK, Cengiz E, Kucukzeybek Y, Karaca B, Atmaca H, Uzunoglu S, Karabulut B, Uslu R.
    Cell Biol Int; 2009 Nov; 33(11):1165-72. PubMed ID: 19716895
    [Abstract] [Full Text] [Related]

  • 7. Zoledronic acid effects interleukin-6 expression in hormone-independent prostate cancer cell lines.
    Asbagh LA, Uzunoglu S, Cal C.
    Int Braz J Urol; 2008 Nov; 34(3):355-63; discussion 364. PubMed ID: 18601766
    [Abstract] [Full Text] [Related]

  • 8. Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells.
    Karabulut B, Erten C, Gul MK, Cengiz E, Karaca B, Kucukzeybek Y, Gorumlu G, Atmaca H, Uzunoglu S, Sanli UA, Baran Y, Uslu R.
    Cell Biol Int; 2009 Feb; 33(2):239-46. PubMed ID: 19103299
    [Abstract] [Full Text] [Related]

  • 9. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM, Senaratne SG, Clarke IA, Kirby RS, Colston KW.
    J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
    [Abstract] [Full Text] [Related]

  • 10. Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines.
    Ullen A, Schwarz S, Lennartsson L, Kalkner KM, Sandstrom P, Costa F, Lennernas B, Linder S, Nilsson S.
    Scand J Urol Nephrol; 2009 Jul; 43(2):98-103. PubMed ID: 19101859
    [Abstract] [Full Text] [Related]

  • 11. Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid.
    Ullén A, Lennartsson L, Harmenberg U, Hjelm-Eriksson M, Kälkner KM, Lennernäs B, Nilsson S.
    Acta Oncol; 2005 Jul; 44(6):644-50. PubMed ID: 16165924
    [Abstract] [Full Text] [Related]

  • 12. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U.
    Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
    Boudreau RT, Conrad DM, Hoskin DW.
    Cell Signal; 2007 Jan 15; 19(1):139-51. PubMed ID: 16844342
    [Abstract] [Full Text] [Related]

  • 14. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation.
    Coxon JP, Oades GM, Kirby RS, Colston KW.
    BJU Int; 2004 Jul 15; 94(1):164-70. PubMed ID: 15217454
    [Abstract] [Full Text] [Related]

  • 15. Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines.
    Dirican A, Erten C, Atmaca H, Bozkurt E, Kucukzeybek Y, Varol U, Oktay Tarhan M, Karaca B, Uslu R.
    J BUON; 2014 Jul 15; 19(4):1055-61. PubMed ID: 25536616
    [Abstract] [Full Text] [Related]

  • 16. Ceramide produces apoptosis through induction of p27(kip1) by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells.
    Kim SW, Kim HJ, Chun YJ, Kim MY.
    J Toxicol Environ Health A; 2010 Jul 15; 73(21-22):1465-76. PubMed ID: 20954073
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms.
    Quinn JE, Brown LG, Zhang J, Keller ET, Vessella RL, Corey E.
    Prostate Cancer Prostatic Dis; 2005 Jul 15; 8(3):253-9. PubMed ID: 15999121
    [Abstract] [Full Text] [Related]

  • 18. Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines.
    Varol U, Degirmenci M, Karaca B, Atmaca H, Kisim A, Uzunoglu S, Sezgin C, Sanli UA, Uslu R.
    Tumour Biol; 2015 Feb 15; 36(2):779-86. PubMed ID: 25293519
    [Abstract] [Full Text] [Related]

  • 19. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA, Howitt IJ, Ackland SP, McCluskey A.
    Cancer Chemother Pharmacol; 2004 Mar 15; 53(3):225-32. PubMed ID: 14648018
    [Abstract] [Full Text] [Related]

  • 20. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.
    Corey E, Brown LG, Quinn JE, Poot M, Roudier MP, Higano CS, Vessella RL.
    Clin Cancer Res; 2003 Jan 15; 9(1):295-306. PubMed ID: 12538482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.